#1Investor presentation February 2022 Givaudan Human by nature#2What we do C 2022 General Investor Relations presentation January 2022 2#3Soft Moc www.weltmed.com NN TAYLOR Givaudan products M Dall drive millions of consumer decisions every day! M 2022 General Investor Relations presentation January 2022 3#4Fragrance & Beauty, Taste & Wellbeing, provide our customers compounds, ingredients and integrated solutions that engage consumers Beverages Snacks Givaudan Neutraceuticals Savoury Oral care Personal care Dairy Sweet goods 2022 General Investor Relations presentation Fabric care H Fine Fragrances Household Beauty & skin care February 2022 4 4#5nc C How we do it LS G 2022 General Investor Relations presentation 7731 SUSON 5#6A unique business model driven by our purpose Creating for happier, healthier lives with love for nature. • • • Winning business assumes: being on a core supplier list, submitting a brief, developing a solution and being selected by the customer Our products are unique co-creations with our customers: • • • Consumer-differentiating, bespoke, value-added Fragrance and Beauty, Taste and Wellbeing solutions driven by innovation Agility and service are key Scent and taste determine consumer purchase and repeat decisions whilst representing only a minor fraction of costs 0.5-2.0% in flavours and consumer fragrances to 4-6% in fine fragrances, i.e. a very minor portion of the end product costs High barriers to entry and high shifting costs for customers Givaudan 2022 General Investor Relations presentation February 2022 60#7A unique business model with high barriers to entry Mastering complexity is a key feature of our space • A research-driven innovation process and a deep understanding of consumer preferences around the world • Sustainability goals creating significant innovation opportunities (e.g. move from non- renewable to renewable, etc.) • IP / formulae owned by Givaudan • • • Mastering high complexity and volatility at every step: • • >11,000 raw materials and a sophisticated supply chain with over 3,000 raw material suppliers >120,000 products made to order, delivered just in time to >10,000 customers >300,000 customer submissions / product briefs managed annually, and ca. 15% of our portfolio up for review due to the life cycle of products • Compliance and regulations Givaudan 2022 General Investor Relations presentation February 2022 7#8All figures as of 31.12.2021 Givaudan: A naturally-hedged portfolio (products, geography, customers) for consistent growth 6.7 sales in CHF billion 57% of sales in mature markets 43% of sales in high growth markets 16,842 full time employees 185 locations Savoury 37% Beverages 35% Sweet goods 16% Dairy 12% Taste & Wellbeing 54% of Group sales Consumer Products 67% Fine Fragrances 19% Fragrance Ingredients and Active Beauty 14% Fragrance & Beauty 46% of Group sales Our customers 50% multi-national | 50% local and regional | › North America 27% of sales | › > Europe 29% of sales 13 production sites 19% of employees 31 production sites 40% of employees South Asia, Middle East 8% of sales 9 production sites 8% of employees 79 production sites Givaudan 2022 General Investor Relations presentation > Latin America 11% of sales 9 production sites 14% of employees | > Asia Pacific 25% of sales 17 production sites 19% of employees February 2022 8 00#9Operating in a significant addressable market Givaudan's expanded market space worth CHF 42bn Givaudan market share as of 2020 Market potential as of 2020 消 יה + 00000 Flavour & Taste 13.1 bn CHF Market Potential as of 2020 Source: Based on Givaudan internal estimates Functional & Nutrition (Sense, Health & Nutrition) 14.1 bn CHF Market Potential as of 2020 (Givaudan scope of activities) Givaudan 2022 General Investor Relations presentation of + Fragrance & Beauty 14.8 bn CHF Market Potential as of 2020 February 2022 6#10A research-driven innovation process Supported by unrivalled capabilities and innovation > 69 Creation and application Centres -0000 >>120,000 CHF 562 mln Products sold per year R&D spend in 2021, 8.4% of sales > 550 Employees in Science & Technology > 3,600 Active patents Innovation initiatives and priorities Supplier enabled innovation partnerships with bioscience companies Delivering differentiating technologies and solutions in Flavours, nutritional and functional ingredients (clean label delivery systems, health and wellbeing solutions etc.) Enabling novel consumer experiences in Fragrances: naturals, new sensory experiences, sustainable new molecules and precursors etc. Givaudan 2022 General Investor Relations presentation February 2022 10#11Business processes enabled by digital tools. Selected digital initiatives Carto - AI enabled creative design Consumer and customer foresight Robotic process Factory 2.0 Traceability automation A101 A product creation experience: Playful and multi-sensorial human/machine interaction Smart suggestions powered by AI Collaboration-oriented environment enabling customer co-creation Discover new consumer behaviours through advanced analysis of social media and other external data Capturing insights and converting them into business foresights Create a virtual workforce to take over repetitive tasks, creating bandwidth for more value added activities E.g. supply chain, HR, compliance forms, etc. Identify how technology can improve the manufacturing environment: - - - Automation (robots, processes) Safety (training, monitoring) Decision making (forecasting, predictive maintenance) Sustainability (greener processes) products and their Guarantee traceability of constituents, from source to consumer Leverage technology to enable source-to-consumer traceability of raw materials Track biodiversity impact, carbon footprint, water waste thanks to this traceability Givaudan 2022 General Investor Relations presentation February 2022 11#12Value creation through acquisitions Our strategy in motion Induchem Active Beauty 2014 2015 2016 Vika Natural flavours Activ International Natural flavours 2017 Fragrance Oils L&R Fragrance Cosmetics business of Indena Active Beauty Ungerer Speciality Ingredients Flavours & Fragrances Golden Frog drom Fragrances Naturals Cosmetics business of AMSilk Active Beauty 2018 2019 2020 2021 Soliance Active Beauty ~ CHF 1.6 billion of incremental revenues Spicetec Naturals Integrated solutions CHF 4.1 billion invested in acquisitions Expressions Parfumées L&R Fragrances Albert Vieille Naturals Aromatherapy Centroflora Nutra Naturals Naturex Naturals Health and wellbeing Active Beauty Givaudan 2022 General Investor Relations presentation Alderys Biotechnology Myrissi Artificial intelligence DDW Natural colours Custom Essence L&R Fragrances February 2022 12#13Future value creation Through our 2025 strategy 2022 General Investor Relations presentation 33 13#14Givaudan's purpose Driving sustainable performance, and acting as a force for good Creations Let's imagine together with customers that through our creations more people will enjoy happier, healthier lives Givaudan Creating for happier, healthier lives with love for nature. Let's imagine together iti Communities Let's imagine together that all communities benefit by working with Givaudan Nature Let's imagine together that we show our love for nature in everything we do Working to become a Certified B People Let's imagine together that Givaudan is a place where we all love to be and grow 7006 FINDER EQUALITY Corporation PARTNERSHIPS 12 13 QO 2022 General Investor Relations presentation February 2022 14#15Megatrends Impacting 2025 strategy Consumer base is growing Living longer and more consciously Sustainability is of high concern Trend > Impact > • Givaudan Asia and Africa leading the way · • COVID-19: E-commerce, self-care and localisation gain importance Consumers are focussing on health and • ⚫ transparency • • Consumers will buy more consciously Responsible businesses will create a positive impact on society and the planet 2022 General Investor Relations presentation • Consumers will buy more online and increase spending on self-care Localisation will be even more important February 2022 15#16Strategy 2025 Committed to Growth, with Purpose Creations We create inspiring solutions for happier, healthier lives People We nurture a place where we all love to be and grow + EXPAND THE PORTFOLIO GROWING TOGETHER WITH OUR CUSTOMERS FOCUSSED MARKET STRATEGIES REACH EXTEND CUSTOMI Excellence, Innovation & Simplicity - in everything we do PURPOSE LINKED TARGETS 4-5% GROWTH Givaudan Nature We show our love for nature through impactful actions Communities We bring benefits to all communities that work with us >12% FCF February 2022 16#17Strategy 2025 Performance commitments Sales growth 4.0 – 5.0% - 2021 2025 Average Like for Like¹ Sales Growth Free cash flow >12% of Sales 2021 2025 - Average FCF2 as % of sales Purpose commitments Purpose linked targets 2021 2025 Progress towards all published purpose targets 1. Like-for-like (LFL) is defined as: (a) sales calculated using the invoicing exchange rates of the prior year, (b) excluding sales of businesses acquired from the acquisition date until the period end date, up to 12 months from the acquisition date, and (c) excluding sales of the businesses disposed of from the disposal date until the period end date of the comparable prior period 2. Free Cash Flow (FCF) refers to operating cash flow after net investments, interest paid, lease payments and purchase and sale of own equity instruments Givaudan 2022 General Investor Relations presentation February 2022 17#18Leveraging the full portfolio to reach our growth ambitions in Taste & Wellbeing 0% Flavour and taste Health, wellbeing and nutrition Strengthen our core Build market leadership Flavour and taste Naturals Protein Natural functional ingredients Colouring Preservatives Texturants Natural nutritional ingredients Microbiome Botanicals Givaudan Integrated solutions 2022 General Investor Relations presentation Naturals space HW&N space February 2022 18#19New and superior product offering in Fragrance & Beauty Biotechnology Leverage our capabilities and acquisitions for our ingredients Delivery systems Provide the next generation of bio-caps Givaudan .......... 2022 General Investor Relations presentation Beauty Further expand our offering in Active Beauty Naturals Provide our customers with the most innovative and qualitative ingredients February 2022 19#20Purpose and 2025 strategy Encapsulate our approach to ESG 2022 General Investor Relations presentation February 2022 20#21Purpose-linked targets Encapsulate our approach to ESG Creations ESG Nature EG People SG By 2030 We will double our business through creations that contribute to happier, healthier lives. Before 2030 Our operations' carbon emissions will be cut by 70% and our supply chain emissions by 20% We will replace single-use plastics with eco-friendly alternatives across our sites and operations Before 2040 Our operations' will be climate positive and our supply chain emissions will be cut by 50% Before 2050 Our supply chain will be climate positive Before 2025 Everyone on our sites will have access to mental and physical health initiatives, tools and training We will reduce our total recordable injury rate by 50% We will be rated among the leading employers for inclusion globally Before 2030 50% of our senior leaders will be from high growth markets 50% of our senior leadership will be women E Environment S Social G Governance Givaudan TMT SSS 2022 General Investor Relations presentation Communities ESG By 2030 • • We will source all materials and services in a way that protects people and the environment We will improve the lives of millions of people in communities where we source and operate D M 12 15 IN NUM February 2022 21#22History of acting sustainably with solid track record of ESG ratings Confidence in achieving ambitious purpose targets CDP CDP DISCLOSURE INSIGHT ACTION A LIST 2021 CLIMATE DISCLOSURE INSIGHT ACTION A LIST 2021 CDP DISCLOSURE INSIGHT ACTION SUPPLIER ENGAGEMENT LEADER WATER 2021 GOLD 2021 ecovadis Sustainability Rating SUSTAINALYTICS SIX FTSE4Good Index Series MSCI ESG RATINGS RR RAA AAA Double 'A rating' for climate and water for three consecutive years CDP Leaderboard recognition for supplier engagement¹ Awarded the EcoVadis Gold medal, ranking us in the top 5% of more than 75,000 businesses Rated as 'low-risk' in 2021 with a score of 19.1 and a chemicals industry ranking 13 out of 480 Included in SXI Swiss Sustainability 25 Index Ranked in the top 2% in the FTSE4Good Index Series, among our peers MSCI ESG AAA Rating since 2017 Transparent disclosure of comprehensive, audited ESG data based on reporting standards Givaudan has applied the GRI Deco GRI frameworks since 2010 IR Givaudan has adopted Integrated reporting since 2016 1. 2021 score published end of Feb. 2022 Givaudan 2022 General Investor Relations presentation February 2022 22 LAS#23Creations for happier, healthier lives of millions of people Doubling our business by 2030 We will impact millions of lives by working with our customers to develop creations for happier, healthier lives By 2030 We will double our business through creations that contribute to happier, healthier lives Givaudan Taste & Wellbeing Going beyond great taste to create food experiences that do good and feel good, for body, mind and planet • Flavour and taste solutions: authentic flavours, kitchen ingredients, taste- enhancing technologies Natural functional ingredients: colours, preservatives, texturants • Natural nutritional ingredients: microbiome, botanicals Fragrance & Beauty Craftsmanship, creativity, and passion for happier, healthier lives through fragrances for every moment • • Consumer products for personal, home, fabric and oral care • Fragrances and beauty products that spark happiness and delight Fragrances to improve emotional wellbeing: leveraging neuro-sciences to enhance sleep, emotional benefits and wellbeing Plant-based food: non-animal protein alternatives • Solutions to reduce undesirable ingredients (sugar, salt, fat) and add health- supporting nutrients (vitamins, minerals fibers) 2022 General Investor Relations presentation February 2022 23#24Status 2021 Targets Sustainable value creation Having a positive impact on nature 타 Emissions Scope 1+2+3 Before 2050 We will be a climate- positive business¹ Electricity Renewable sources By 2025 Power 100% of our sites with renewable electricity Water Efficiency By 2030 Improve water 25% efficiency by on sites facing water stress² Waste Efficiency Current target Reduce waste by per tonne of 4% product (year on year average)³ Plastics Alternatives Before 2030 Replace single- use plastics with eco-friendly alternatives Scope 1+2 -31% 84% -4% Scope 3 -4% Givaudan 2022 General Investor Relations presentation 2% Absolute reduction since 2015. 100% plastics circularity before 2030 in Progress 1. Scope 1, 2, 3, with intermediate targets before 2030 and 2040. 2. For municipal and groundwater (m³) per tonne of production. baseline 2020. 3. For incinerated and landfilled waste, baseline 2015. February 2022 24#25Givaudan's carbon footprint Our value chain emissions السير Scope 1 5% Emissions generated by our operations Scope 2 2% Emissions generated by our energy supply Scope 3 93% Emissions generated by our supply chain B TARGETS - Scope 3 Before 2050, Our supply chain will be climate positive Actions driving our Roadmap: Engage suppliers in the net- zero journey Refine understanding of our ingredients footprint and drive ingredient innovation Reduce other emissions linked to our value chain About 2,300,000 tonnes GHG emissions per year Givaudan 2022 General Investor Relations presentation February 2022 25#26Sustainable value creation Procurement practices bringing benefits to all involved CHF 2.7 bn >225 People in global procurement worldwide >11,000 Number of different 57% Renewable Raw material / consumable spend per year Sourcing4Good is a step change in our responsible sourcing journey 43% Non-renewable raw materials raw materials sourced raw materials Givaudan Ensures trust and compliance across our entire supply chain It allows us to embark on collaborative transformational projects in selected supply chains Brings end-to-end raw material traceability in key supply chains Builds on our heritage of action in sourcing responsibly. This flagship programme is closely tied to our goal to source all materials and services in a way that protects people and the environment before 2030. 2022 General Investor Relations presentation A full scope with clear priorities across our full portfolio of spend Collaboration with the right partners Traceability, digitisation and progress monitoring Third party validation and an integrated operating model February 2022 26#27Protecting the environment Preserving the biodiversity Supporting the conservation • of diversity of species • Collaborating with the University of California, Riverside (UCR) on Citrus Variety Collection Supporting the care and preservation of the most extensive, unique and diverse citrus collection against threat of greening disease The collection includes 1,000 varieties of citrus fruits from around the globe Givaudan Sustainable use of natural resources through best practices Commitment to forest conservation • • • Devil's Claw sustainable wild collect programme in Namibia Securing the long term supply of this major medicinal plant Organising wild collect of roots and train locals to responsible practices • • • Received the Conservation International's Hero award for the Tonka Bean programme in Venezuela Preserving the forests, the flora and fauna through the Conservation Stewards Program Empowering local communities to conserve 150,000 hectares of forests in the Caura Basin 2022 General Investor Relations presentation February 2022 27#28Fully traceable supply chain Enhancing agricultural practices Contributing to • • • Positive environmental impacts Soil health preservation Biodiversity conservation Increased carbon sequestration in the soil Full traceability of Guarana seeds from the field to the final extract Improved incomes for farmers More market visibility for farmers Supported by Sustainable agricultural practices . • Better fertilisation methods Improved pruning practices to increase fruit yields Investigating plant material improvement Givaudan Example: Guarana (Brazil) An iconic botanical which seeds help fight tiredness and boost physical and mental performance. Used mostly in energy drinks and food supplements. 2022 General Investor Relations presentation February 2022 28#29A place where people love to be and grow Diversity and inclusion A diverse, inclusive organisation to best meet our business goals. Before 2030, we will be an even more balanced and inclusive company Before 2025 > We will be rated amongst the leading employers for inclusion globally Before 2030 50% of our senior leaders will be from high growth markets 2021: 26% Before 2030 > 50% of our senior leaders will be women 2021: 26% Givaudan Inclusive talent experiences Our focus areas Inclusive talent acquisition Inclusive leadership development 2022 General Investor Relations presentation February 2022 29#30A place where people love to be and grow Caring for employees Caring for employee's safety, health and mental well-being DA COME'S Before 2025 > We will reduce our total recordable injury rate by 50% 2021 -22% Caring for our people Our focus areas Before 2025 Everyone on our sites will have access to mental and physical health initiatives, tools and training Givaudan Caring for our place Strengthening our foundation 2022 General Investor Relations presentation February 2022 30#31A strong track record of growth and value creation#32Key investment highlights Givaudan has a strong track record of delivering with excellence A company inspired by its purpose, engaged in the B Corp certification and part of the B Builders Movement A highly resilient / defensive business model: . • • Key products that are the most important part of consumer staples and the decisive factor behind the repurchase decisions of consumers High barriers to entry (complexity, R&D, consumer insight, regulations, etc.) Competition focused on innovation, quality and service, not on price • Natural hedges for sustainable growth: • Diversified exposures to all regions and market segments (including premium, private label and regional players in emerging markets) Emerging markets/urbanisation-driven growth model Consistency in strategy, execution, result delivery and stability of management Givaudan 2022 General Investor Relations presentation February 2022 32#33Value creation at Givaudan Sustained value creation for shareholders Share price evolution vs SMI Dividend per share in CHF 70 70 60 1400% 50 1200% 1000% 40 800% 30 600% 20 400% 10 200% 0% 0 2000 2005 2010 2015 2020 2000 2005 2010 2015 2020 -Givaudan SMI >CHF 40 Billion of Total Shareholder return since the IPO Average annual yield of 13.6% vs 4.6% of SMI Givaudan 2022 General Investor Relations presentation February 2022 33#34Value creation at Givaudan Dividend per share, increasing 3.1% over 2020 * Subject to approval of shareholders at the AGM in March 2022 47 50 54 56 58 60 62 64 66* 36 20 22 20.6 21.5 6.5 7 8.1 15.4 16.3 17.6 18.8 19.5 390 549 437 512 662 604 720 597 594 703 787 811 843 do…....|||| 203 2000 340 2001 273 295 289 262 157 145 117 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Free Cash Flow -Dividend Givaudan 2022 General Investor Relations presentation February 2022 34 4#352021 Full Year Results Strong start to the 2025 strategic cycle#362021 Full year results Performance highlights • Sales of CHF 6.7 billion, up 7.1% on a like-for-like✶ basis and 5.7% in Swiss francs • All 2025 strategic focus areas on track and contributing to the results EBITDA of CHF 1,482 million, an increase of 6.0% - EBITDA margin of 22.2% compared to 22.1% in 2020 • • Comparable EBITDA margin of 22.5% compared to 22.8% in 2020 • Free cash flow of CHF 843 million, an increase of 3.9% over 2020 of 12.6% of sales • Proposed dividend of CHF 66.00 per share, up 3.1% year-on-year *Like-for-like: excludes the impact of currency, acquisitions and disposals Givaudan 2022 General Investor Relations presentation - Free cash flow February 2022 36#37Sales performance Strong growth in both divisions In CHF million 6,322 6,684 ■FY 2020 ■FY 2021 2,924 3,091 3,398 3,593 Group Fragrance & Beauty Taste & Wellbeing 7.1% 5.7% 6.6% 5.8% 7.6% 5.7% % 2021 growth on LFL* basis % 2021 growth in CHF *Like-for-like: excludes the impact of currency, acquisitions and disposals Givaudan 2022 General Investor Relations presentation February 2022 37#38Sales evolution by region All regions contributing to the growth In CHF million 674 723 ■FY 2020 FY 2021 2,449 2,278 1,602 1,688 1,768 1,824 LATAM APAC NOAM EAME 14.4% 7.3% * Like-for-like: excludes the impact of currency, acquisitions and disposals 5.7% 5.4% 4.8% 7.8% % 2021 growth on LFL* basis 3.2% 7.5% % 2021 growth in CHF Givaudan 2022 General Investor Relations presentation February 2022 38#39Operating performance Group EBITDA in CHF million 42.1% Gross margin in % 42.7% 1,482 1,397 FY 2020 22.1% 22.8% EBITDA Margin Comparable EBITDA Margin Sales of CHF 6,684 million, an increase of 7.1% on a like-for-like basis and 5.7% in Swiss francs EBITDA of CHF 1,482 million, increased from CHF 1,397 million in 2020 EBITDA margin of 22.2% compared to 22.1% in 2020, with the comparable EBITDA margin at 22.5% versus 22.8% in 2020 FY 2021 22.2% As % of sales 22.5% *Like-for-like: excludes the impact of currency, acquisitions and disposals Givaudan 2022 General Investor Relations presentation February 2022 39#40Operating performance Fragrance & Beauty Sales in CHF million 677 EBITDA in CHF million 696 3,091 2,924 +6.6% LFL growth Sales of CHF 3,091 million, an increase of 6.6% on a like-for-like basis and 5.8% in Swiss francs EBITDA of CHF 696 million, increased from CHF 677 million in 2020 The increase was mainly driven by higher sales and the contribution of the recent acquisitions in terms of growth and synergies, despite the increased pressure on supply chain costs across the business Acquisition and restructuring costs of CHF 2 million, compared to CHF 7 million in 2020 EBITDA margin of 22.5% compared to 23.2% in 2020, with the comparable EBITDA margin at 22.6% versus 23.6% in 2020 FY 2020 FY 2021 23.2% EBITDA Margin 22.5% As % of sales 23.6% Comparable EBITDA Margin 22.6% *Like-for-like: excludes the impact of currency, acquisitions and disposals Givaudan 2022 General Investor Relations presentation February 2022 40 40#41Operating performance Taste & Wellbeing Sales in CHF million EBITDA 720 in CHF million 786 3,593 +7.6% LFL growth 3,398 FY 2020 21.2% 22.1% EBITDA Margin FY 2021 21.9% Comparable EBITDA Margin 22.4% *Like-for-like: excludes the impact of currency, acquisitions and disposals Givaudan Sales of CHF 3,593 million, an increase of 7.6% on a like-for-like basis and of 5.7% in Swiss francs EBITDA of CHF 786 million, increased from CHF 720 million in 2020 Acquisition and restructuring costs of CHF 20 million, compared to CHF 32 million in 2020, largely related to the integration of the recently acquired companies and ongoing optimisation of the manufacturing footprint EBITDA margin of 21.9% compared to 21.2% in 2020. The comparable EBITDA margin was 22.4% versus 22.1% in 2020 As % of sales 2022 General Investor Relations presentation February 2022 41#42Operating performance Fragrance & Beauty Sales in CHF million 677 EBITDA in CHF million 696 3,091 2,924 +6.6% LFL growth Sales of CHF 3,091 million, an increase of 6.6% on a like-for-like basis and 5.8% in Swiss francs EBITDA of CHF 696 million, increased from CHF 677 million in 2020 The increase was mainly driven by higher sales and the contribution of the recent acquisitions in terms of growth and synergies, despite the increased pressure on supply chain costs across the business Acquisition and restructuring costs of CHF 2 million, compared to CHF 7 million in 2020 EBITDA margin of 22.5% compared to 23.2% in 2020, with the comparable EBITDA margin at 22.6% versus 23.6% in 2020 FY 2020 FY 2021 23.2% EBITDA Margin 22.5% As % of sales 23.6% Comparable EBITDA Margin 22.6% *Like-for-like: excludes the impact of currency, acquisitions and disposals Givaudan 2022 General Investor Relations presentation February 2022 42#43Free cash flow Sustained underlying performance In CHF million Givaudan 811 FY 2020 +3.9% 12.8% As % of sales 843 Free cash flow of CHF 843 million, compared to CHF 811 million in 2020. Free cash flow is 12.6% of sales compared to 12.8% in 2020 Operating cash flow of CHF 1,288 million, compared to CHF 1,189 million in 2020 Total net investments of CHF 247 million, or 3.7% of sales, as the Group continues to invest in growth and the integration of recent acquisitions. The net investments in 2020 were 3.4% of sales Net Working capital of 24.0% of sales compared to 24.4% in 2020 FY 2021 12.6% 2022 General Investor Relations presentation February 2022 43 33#44Disclaimer No warranty and no liability: While Givaudan is making great efforts to include accurate and up-to-date information, we make no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided on this handout and disclaim any liability for the use of it. No offer and no solicitation: The information provided on this handout does not constitute an offer of or solicitation for the purchase or disposal, trading or any transaction in any Givaudan securities. Investors must not rely on this information for investment decisions. Forward-looking information: This handout may contain forward-looking information. Such information is subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly from those presented. Copyright © 2022 Givaudan SA. All rights reserved. Givaudan 2022 General Investor Relations presentation February 2022 44#45Investor relations contact: Pierre Bénaich Head of Investor and Media Relations T +41 22 780 9053 E [email protected] Follow us on social media @givaudan in f Givaudan Human by nature